Haleon
HLN
9.02
+0.15
+1.69%
Haleon
US · HLN
#553 by market cap
Listed 2022
9.02
+0.15
+1.69%
Live - 5344 symbols - heartbeat 53s ago
· 2026-10-08 06:32
Pre-market
9.09
+0.78%
After-hours
9.02
0.00%
Overnight
9.07
+0.55%
- Market cap
- 39.67B
- P/E (TTM)i
- 18.87
- P/Bi
- 1.83
- EPSi
- 0.49
- Div yieldi
- 2.11%
- 52W posi
- 17%
Reader sentiment
Are you bullish or bearish on HLN?
Anonymous reader poll. Unscientific, not investment advice.
About Haleon
Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom.
- Founded
- 2021
- CEO
- Mr. Brian James McNamara
- Employees
- 24,535
- Headquarters
- Weybridge, Surrey, United Kingdom of Great Britain and Northern Ireland (the)
- Fiscal year end
- 12-31
- Website
- haleon.com
Company profile
- Exchange
- US
- Symbol
- HLN
- Market-cap rank
- #553
- Listing date
- 2022-07-18
- Market cap
- 39.67B
- Float cap
- 39.53B
- Shares out
- 4.40B
- Float shares
- 4.38B
Sectors & themes
Drug Manufacturers - Specialty & Generic
Fractional Shares JP
Quote time 2026-10-08 06:32:47 · For reference only, not investment advice and not tailored to your situation.